The following IPOs are expected to price this week:
Colony American Homes (CAHS), a REIT managed by Colony Capital focused on leasing single-family homes, plans to raise $245 million by offering 20.0 million shares at a price range of $11.50 to $13.00. At the midpoint of the proposed range, Colony American Homes would command a market value of $3.0 billion. Colony American Homes, which was founded in 2012, booked $20 million in sales over the last 12 months. The New York, NY-based company plans to list on the NYSE under the symbol CAHS. Credit Suisse, Morgan Stanley and BofA Merrill Lynch are the joint bookrunners on the deal.
LightInTheBox (LITB), an e-commerce company that sells China-made goods to Europe and the Americas, plans to raise $79 million by offering 8.3 million shares at a price range of $8.50 to $10.50. At the midpoint of the proposed range, LightInTheBox would command a market value of $472 million. LightInTheBox, which was founded in 2007, booked $236 million in sales over the last 12 months. The Beijing, China-based company plans to list on the NYSE under the symbol LITB. Credit Suisse and Stifel are the joint bookrunners on the deal.
RCS Capital (RCAP), a wholesale broker-dealer of non-traded REIT products for American Realty, plans to raise $55 million by offering 2.8 million shares at a price range of $19.00 to $21.00. At the midpoint of the proposed range, RCS Capital would command a market value of $535 million. RCS Capital, which was founded in 2007, booked $470 million in sales over the last 12 months. The New York, NY-based company plans to list on the NYSE under the symbol RCAP. JMP Securities, Ladenburg Thalmann & Co., Aegis Capital Corp. and Maxim Group LLC are the joint bookrunners on the deal.
Textura (TXTR), which provides on-demand project management software for the construction industry, plans to raise $56 million by offering 4.0 million shares at a price range of $13.00 to $15.00. At the midpoint of the proposed range, Textura would command a market value of $304 million. Textura, which was founded in 2004, booked $16 million in sales over the last 12 months. The Deerfield, IL-based company plans to list on the NYSE under the symbol TXTR. Credit Suisse and William Blair are the joint bookrunners on the deal.
Renaissance Capital will have Pre-IPO Research available on each of these upcoming IPOs prior to its pricing.
Last week, there were 2 IPO pricings. Epizyme (EPZM), a biotech developing therapeutics for patients with genetically defined cancers, was the week's winner, ending up 53% from its IPO price.
